CBOE vs JPM
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
CBOE exhibits a stable financial profile with a Piotroski F-Score of 4/9 and a strong balance sheet characterized by low debt/equity (0.31). While the stock is trading near its growth-based intrinsic value of $307.39, it is significantly overpriced relative to its defensive Graham Number of $107.29. Exceptional earnings growth (60.5% YoY) and a consistent track record of earnings beats are offset by a high PEG ratio (3.75) and bearish short-term signals. The convergence of a 'Hold' analyst consensus, bearish insider activity, and a weak technical trend suggests the stock is currently fully valued.
JPM exhibits a concerning Piotroski F-Score of 2/9, indicating weak short-term fundamental health, and currently trades at a significant premium to both its Graham Number ($239.11) and Intrinsic Value ($140.07). While the company maintains a strong ROE of 16.13% and dominant market positioning, negative YoY earnings growth (-3.60%) and bearish insider activity from the CEO and CFO signal internal caution. The stock's current price of $313.68 suggests the market is pricing in a growth premium that is not currently supported by the deterministic health or value metrics.
Compare Another Pair
Related Comparisons
CBOE vs JPM: Head-to-Head Comparison
This page compares Cboe Global Markets, Inc. (CBOE) and JPMorgan Chase & Co. (JPM) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.